All CLIA-waived tests
CLIA-waived analyte
luteinizing hormone (lh): CLIA-waived test status.
LUTEINIZING HORMONE (LH) appears on the FDA Currently Waived Analytes list — at least one test system for this analyte is categorized CLIA-waived.
Last reviewed 2026-07-03
Waived status is device-specific and can change. This page does not confirm that a specific Luteinizing Hormone (LH) device is waived — verify your exact test system in the FDA CLIA database.
What "CLIA-waived" means for Luteinizing Hormone (LH)
- The FDA categorizes test systems by complexity. "Waived" is the lowest-complexity tier — tests simple enough that the FDA and CMS allow them under a Certificate of Waiver.
- LUTEINIZING HORMONE (LH) being on the waived-analytes list means one or more cleared devices for it are waived. Your specific device and manufacturer determine the actual categorization.
- Running it in a clinic still requires a CLIA Certificate of Waiver and adherence to the manufacturer's instructions for use.
Add it under a waiver
Prepare a CMS-116 Certificate of Waiver listing Luteinizing Hormone (LH) with its test name, manufacturer, and estimated annual volume. Check your state — several add a lab-license step.
Check my test menuCLIA waiver requirements by state →